Aim of the study is to investigate what the influence is of insomnia on driving performance and to what extent this influence is attenuated by the use of hypnotics. Therefore, over-the-road driving performance of treated and untreated patients…
ID
Source
Brief title
Condition
- Sleep disturbances (incl subtypes)
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The main study parameter is Standard Deviation of Lateral Position (SDLP in cm)
in the highway driving test.
Secondary outcome
Time to speed adaptation (in msec) and brake reaction time (in msec) in the car
following test.
Cognitive and psychomotor tests: 15-Word Learning Test; Critical Tracking Task;
Divided Attention Task; Stop Signal Task; Psychomotor Vigilance Task; Digit
Span Backward and Forward.
Subjective evaluations: Subjective alertness BOnd &Lader Visual Analogue
Scales.
Background summary
One of the main problems associated with the use of hypnotics is residual
daytime sleepiness the morning after bedtime administration. This poses a
crucial problem for users of hypnotics whose activity the next morning involves
skilled work and in whom impairment of performance, such as driving a car,
could be a danger to themselves or others. It is, therefore, for the safety of
patients using hypnotics important to have knowledge on the extent of influence
the hypnotics have on their daily activities, particularly driving. Information
on the severity of residual effects of hypnotics is mainly derived from
experimental studies in young healthy volunteers after administration of a
single dose. However, the majority of hypnotic users are elderly (i.e. 55 years
or older) and use hypnotics for longer periods, which may result in tolerance
towards the residual effects. Moreover, hypnotic users have sleep complaints
which may have deleterious consequences on daytime performance. A
hypnotic-induced night of sleep is then expected to improve daytime
functioning, despite the possible sedating residual effects of the hypnotic.
Study objective
Aim of the study is to investigate what the influence is of insomnia on driving
performance and to what extent this influence is attenuated by the use of
hypnotics.
Therefore, over-the-road driving performance of treated and untreated patients
complaining of insomnia is compared with that of healthy controls matched for
age, gender and annual mileage.
Study design
The study will be conducted according to a 3x2 parallel group design with three
groups (users, non-users and matched controles) and two within subject
conditions (habituation and baseline).
Study burden and risks
Subjects will visit the study centre and be monitored by one of the
investigators for examination during medical screening (2 hours); for training
of cognitive tests and highway driving test (4 hours); and for one habituation
period and one baseline period consisting of an evening, night and following
morning (in total 32 hours, including 16 hours of sleep). Blood samples are
drawn during screening (12 mL) and test periods (8 mL). During test periods
subjects perform cognitive tests and a highway driving test. An on-the-road
driving test has been chosen as it is considered more sensitive than the use of
driving simulators. The latter has been shown not to be sensitive enough to
predict residual drug effects in the on-the-road driving tests of two classical
benzodiazepines.
It is still unclear whether chronic insomnia has significant impairing
consequences on daily life routines such as driving a car. Moreover, it is
unclear whether use of hypnotics can attenuate the presumed effects of
insomnia. In addition it is unknown whether the residual effects hypnotics are
absent in chronic users.
This study is relevant in order to inform patients and physicians adequately on
the effects of insomnia and the possible residual effects of hypnotics, in
particular with respect to their effects on driving performance.
Epidemiological data show some evidence, but the results have not yet been
replicated in experimental studies. Therefore, an on-the-road driving test has
been chosen as it is considered more sensitive than the use of driving
simulators. The latter has been shown not to be sensitive enough to predict
residual drug effects in the on-the-road driving tests of two classical
benzodiazepines. In addition, the current lack of experimental evidence seems
to be a possible result of a lack of ecologically valid tests.
Postbus 616
6200 MD Maastricht
Nederland
Postbus 616
6200 MD Maastricht
Nederland
Listed location countries
Age
Inclusion criteria
healthy (except for patients with complaints of insomnia)
age 55 year or older
possession of a valid drivers license
average annual driving experience of 3000 km per year over the last three years
Exclusion criteria
abuse of alcohol, nicotine and cafeine
use of medication that might affect driving performance (except hypnotics)
For patients: Sleep-Related Breathing Disorders; Circadian Rhythm Sleep Disorders; Sleep-Related Movement Disorders
Design
Recruitment
Medical products/devices used
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
EudraCT | EUCTR2007-002154-28-NL |
CCMO | NL17428.068.07 |